Skip to content

Effect of Ramazolam Benzenesulfonate on Awakening period of General Anesthesia

Effect of Ramazolam Benzenesulfonate on Awakening period of General Anesthesia - Effect of Ramazolam Benzenesulfonate on Awakening period of General Anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058385
Enrollment
Unknown
Registered
2022-04-08
Start date
2021-08-31
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia and sedation

Interventions

Remazolam benzenesulfonate group:Rimazolam was induced under general anesthesia at 4-12mg/kg/h and maintained at 0.7mg/kg/h
The propofol group:Propofol was induced at 2.0-2.5mg/kg and maintained at 4-10mg/kg/h

Sponsors

People's Hospital of Ningxia Hui Autonomous region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 60 years old <= Age <= 80 years old, gender is not limited, nationality is not limited; 2. Elective surgery under general anesthesia, expected to be 2 hours <= operation time <= 4 hours; 3. Agree to participate in this study and sign an informed consent form; 4. ASA level I-III.

Exclusion criteria

Exclusion criteria: 1. Refuse to participate in this researcher; 2. Preoperative schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis; 3. Unable to communicate because of coma, severe dementia, language disorder, end-stage disease, etc. 4. Cerebral infarction, cerebral hemorrhage, craniocerebral surgery, craniocerebral trauma; 5. Combined anesthesia (general anesthesia combined with other anesthetic methods, general anesthesia + intraspinal anesthesia, general anesthesia + regional nerve block, general anesthesia + incision block); 6. Inhalation anesthesia; 7. Critical condition (preoperative ASA grade >= IV); severe renal function damage (requiring renal replacement therapy); severe liver function damage (Child-Pugh grade C); 8. The attending physician or researcher believes that there are other situations that are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Agitation during awakening;Postoperative delirium;OAA/S scale;PACU scale;NRS scale;VAS scale;Postoperative incidence;Bispectral index;Blood pressure;Heart Rate;breathe;degree of blood oxygen saturation;

Countries

China

Contacts

Public ContactQingshan Ye

Department of Anesthesiology, people's Hospital of Ningxia Hui Autonomous region

yeqingshan@hotmail.com+86 17395055188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026